双能CT在体显示COVID-19肺微血管受累
本研究利用双能CT评估COVID-19肺炎患者肺微血管受累情况,并判断血管改变是否随病程变化。DECT可显示肺内碘对比剂分布,作为肺灌注的替代标志物。研究聚焦于磨玻璃影和实变两种模式下的灌注血容量变化。
要点
- DECT可无创评估COVID-19肺炎肺灌注血容量改变。
- 磨玻璃影区域灌注血容量增加,实变区域灌注血容量降低。
- 血管改变可能随COVID-19病程不同而有所差异。
核心结论
- COVID-19肺炎存在肺微血管受累,DECT显示沿病程出现两种肺灌注模式。
研究设计与样本
- 采用双能CT评估COVID-19肺炎患者肺微血管受累的在体研究。
- 研究目的为判断血管改变是否随病程变化。
主要发现
- 磨玻璃影区域灌注血容量(PBV)增加。
- 实变区域灌注血容量(PBV)降低。
临床怎么用
- DECT可作为评估COVID-19肺炎肺灌注的影像学工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In COVID-19 pneumonia, dual-energy computed tomography has shown two patterns of lung perfusion along the course of the disease: an increase in perfusion blood volume (PBV) with ground-glass opacities and a decrease in PBV with consolidation https://bit.ly/2Zh0XcI Vascular involvement in coronavirus disease 2019 (COVID-19) has been suggested by several observations, such as the high rate of pulmonary embolism [1], the prothrombotic state and the proinflammatory biological profile [2, 3], as well as the pathological findings of severe endothelial injury and diffuse thrombosis [4]. Dual-energy computed tomography (DECT) allows specific imaging of the iodinated contrast agent distribution within the lung, which has been demonstrated as a surrogate marker of lung perfusion [5, 6]. Therefore, our goal was to assess in vivo pulmonary microvascular involvement in patients with COVID-19 pneumonia by using DECT and to determine whether vascular changes vary during the course of the disease.
引用
- Si-Mohamed S, Chebib N, Sigovan M, et al. In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography. Eur Respir J. 2020. PMID: 32943402. doi:10.1183/13993003.02608-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。